T 0401/16 (Bilayer pharmaceutical tablet / BOEHRINGER INGELHEIM) of 05.11.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T040116.20201105
- Date of decision
- 5 November 2020
- Case number
- T 0401/16
- Online on
- 25 January 2021
- Petition for review of
- -
- Application number
- 10179142.4
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Bilayer pharmaceutical tablet comprising telmisartan and a diuretic
- Applicant name
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Opponent name
- reuteler & cie SA
Laboratorios Liconsa, S.A.
Generics [UK] Limited
LEK Pharmaceuticals d.d. - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- Rules of procedure of the Boards of Appeal Art 12(4) (2007)Rules of procedure of the Boards of Appeal Art 13(1) (2020)Rules of procedure of the Boards of Appeal Art 25(2) (2020)European Patent Convention Art 114(2) (2007)European Patent Convention Art 76(1) (2007)European Patent Convention Art 123(2) (2007)European Patent Convention Art 83 (2007)European Patent Convention Art 54 (2007)European Patent Convention Art 56 (2007)
- Keywords
- Late-filed evidence - admittance of documents filed in appeal proceedings
Amendments - extension beyond the content of the (earliest) application as filed (no)
Sufficiency of disclosure - (yes)
Public prior use - (no)
Novelty - (yes)
Inventive step - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeals are dismissed.